1. Home
  2. BCBP vs AGEN Comparison

BCBP vs AGEN Comparison

Compare BCBP & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BCB Bancorp Inc. (NJ)

BCBP

BCB Bancorp Inc. (NJ)

HOLD

Current Price

$10.29

Market Cap

139.1M

Sector

Finance

ML Signal

HOLD

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$4.23

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCBP
AGEN
Founded
2000
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.1M
147.4M
IPO Year
2005
1999

Fundamental Metrics

Financial Performance
Metric
BCBP
AGEN
Price
$10.29
$4.23
Analyst Decision
Hold
Buy
Analyst Count
2
2
Target Price
$10.00
$14.50
AVG Volume (30 Days)
91.1K
1.2M
Earning Date
04-21-2026
05-12-2026
Dividend Yield
3.10%
N/A
EPS Growth
N/A
100.00
EPS
0.26
N/A
Revenue
N/A
$42,877,086.00
Revenue This Year
$85.26
$107.63
Revenue Next Year
$6.14
N/A
P/E Ratio
$39.42
$8.89
Revenue Growth
N/A
89.95
52 Week Low
$7.31
$2.71
52 Week High
$10.50
$7.34

Technical Indicators

Market Signals
Indicator
BCBP
AGEN
Relative Strength Index (RSI) 65.25 55.64
Support Level $7.49 $4.09
Resistance Level N/A $4.25
Average True Range (ATR) 0.28 0.29
MACD -0.00 -0.04
Stochastic Oscillator 75.56 50.43

Price Performance

Historical Comparison
BCBP
AGEN

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.

About AGEN Agenus Inc.

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases. Its primary business is immuno-oncology (I-O), where it advances antibody-based programs designed to activate innate and adaptive immunity, overcome tumor immune evasion, and expand the number of patients who may benefit from immunotherapy. The Company's clinical program includes botensilimab (BOT or AGEN1181), both as a monotherapy and in combination with balstilimab (BAL), alongside a portfolio of other clinical-stage immuno-oncology assets that may be used independently or in combination therapies. The Company operates in the United States, which contributes the majority of its revenue, as well as in other international markets.

Share on Social Networks: